Main Menu

Prostate Cancer Targeted Therapy Group 

Professor Johann de Bono’s team investigates new molecular targeted therapies to improve the treatment of patients with advanced prostate cancer.

Team leader

Professor Johann De Bono

Professor Johann De Bono

Divisional Head of Clinical Studies

Professor Johann de Bono is the Head of the Division of Clinical Studies and an international expert in the development of novel anticancer therapies against adult cancers. His team of runs one of the world’s largest phase I clinical trials units for cancer, with >100 staff including dedicated radiology and pathology staff; he also runs a separate team focused on improving prostate cancer care that have led pivotal phase III trials of several prostate cancer drugs including abiraterone, cabazitaxel, enzalutamide and olaparib as well more recently ipatasertib and lutetium-PSMA.

ORCID 0000-0002-2034-595X

Team members

Dr Juliet Carmichael

Clinical Fellow/Speciality Registrar +44 20 3437 6565

Emily Cross

Lead Data Manager +44 20 8722 4286

Bola Fadahunsi

+44 20 8915 6076

Tegan Gumsley Read

Clinical Trial Assistant +44 20 3437 6624

Dr Christina Guo

Clinical Research Fellow +44 20 3437 6238

Sam Legg

Clinical Data Manager +44 20 8722 4191

Dr Vijaya Priyadarshini

Clinical Trial Coordinator Operational +44 20 3437 6904

Dr Alison Reid

Honorary Appointment +44 20 3437 6375

Sheena Vadgama

Senior Clinical Trials Coordinator +44 20 3437 6810